Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Frequent Treatment Improves Diabetic Ulcer Recovery Outcomes

By HospiMedica International staff writers
Posted on 26 Nov 2012
More frequent visits to wound care clinics result in quicker closure of diabetic foot ulcers (DFUs) and venous leg ulcers (VLUs), claims a new study.

Researchers at Healogics (Jacksonville, FL, USA), the largest provider of wound care and related disease management in the United States, conducted a retrospective cohort study involving 206 patients with Wagner grade 1 or 2 DFUs and 215 patients with VLUs in the lower extremities that were treated at nine wound care centers during 2009/2010, and whose wounds had closed. More...
For each type of DFU or VLU, one group had every-other-week visits--defined as more than 10 days between visits in the first 4 weeks--whereas the other group had weekly visits, defined as at least once a week. The main outcome measure was median time to wound closure.

The results showed that for patients with DFUs, 63.8% of wounds had closed in the weekly visit group after 4 weeks, compared with just 2% in the every-other-week group; for patients with VLUs, 78 of 105 wounds (52%) closed in the weekly visit group compared with none in the every-other-week group. After controlling for all covariates, the median time to close for weekly patients was 28 days versus 66 days for patients seen every other week. Adjusted median times to close VLUs in the same groups were 25 versus 55 days. The study was published in the November 2012 issue of Advances in Skin & Wound Care.

“More frequent visits can be extremely beneficial, with implications of lower costs and higher quality of life for patients,” concluded lead author Robert Warriner III, MD, former chief medical officer of Healogics [Dr. Warriner passed away a few months before the article was published].

The mainstay treatment for diabetic ulcers is hyperbaric oxygen therapy (HBOT). During treatment, hyperbaric oxygen is delivered in a chamber pressurized at 1.4 to 3.5 times the normal sea-level atmospheric pressure. The patients breathe 100% oxygen during therapy, sometimes with short “air breaks” of normal air to ensure patients will avoid oxygen toxicity. Patients with DFUs may undergo a total of 40 or more daily treatments, 5 to 6 days per week, for a number of weeks.

Related Links:

Healogics



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Electrode Solution and Skin Prep
Signaspray
Autoclave
Advance
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.